From Root to Ritual

A 2025 study in the International Journal of Trichology confirmed that hair treated with hard water shows significantly reduced tensile strength  vs demonized water. Hard water mineral deposits block moisture, create a film that prevents products penetrating, disrupt scalp pH, and feed the inflammatory environment that the PIILIF research found in 81% of AGA patients. Around 85% of US homes have hard water. Here is what to do.

Moderate exercise improves hair health through five simultaneous pathways — BDNF, insulin sensitivity, cortisol reduction, scalp circulation, and DHT modulation. Overtraining causes telogen effluvium through cortisol elevation, nutritional depletion, and a DHT spike. The difference is not how hard you train — it is whether your recovery matches your output.

Insulin resistance and hair loss are deeply interconnected — 2026 clinical data confirms that the root cause of thinning hair often lies within
metabolic health rather than just on the scalp. When insulin rises chronically, it drives DHT upward, starves follicles of nutrients, and
triggers systemic inflammation. Most hair loss investigations never check fasting insulin. Here is the metabolic driver most people are missing — and what the research says to do about it.
     

Alopecia areata affects approximately 2% of the global population and is the second most common form of hair loss after androgenetic alopecia.
Three JAK inhibitors are now FDA-approved — with 91% of baricitinib patients maintaining regrowth at 2 years. But AA is autoimmune, not hormonal. The mechanism, the diagnosis, and the treatment are completely different from AGA. Here is how to tell the difference — and what the research says about each.

Postpartum hair loss affects 40–50% of new mothers. It peaks 3–4 months after delivery and can shed up to 300 hairs daily. Most women are never told why — or when it ends. The answer is in the biology of what pregnancy does to the hair cycle, why the shedding happens in a wave, and what the follicle needs to reset. Here is the full picture with a month-by-month timeline.

Hair loss is not a cosmetic problem. It is a signal from a biological system that tracks everything — cortisol, ferritin, thyroid hormones, oxygen, sleep, inflammation, microbiome. The hair is the readout. The question is not what to apply to stop it. The question is what the body is trying to communicate. This Sunday — a different way of listening.

A 2025 case-control study of 200 women found hair loss significantly associated with deficiencies in selenium, folate, vitamin B12, vitamin D, and ferritin. Meanwhile, selenium toxicity caused hair loss in 72% of people in one documented supplement outbreak. Zinc excess causes hair loss
through copper depletion. Vitamin A toxicity is a recognized cause of telogen effluvium. The supplement industry has a dosing problem — and most people using hair supplements don't know which side of the line they're on.

HIF-1α — hypoxia-inducible factor 1-alpha — is the protein your hair follicle uses to sense oxygen levels and respond to low-oxygen stress.
 When HIF-1α signaling is impaired, follicles lose their ability to adapt to circulatory stress and begin miniaturizing. A 9-month blinded clinical trial on HIF modulation counteracted hair loss across all
participants. Here is the oxygen biology most hair loss discussions never mention.
     

A double-blind, randomized, placebo-controlled clinical trial found that rosemary-lavender oil increased hair growth rate by 57%, improved thickness by 68%, increased density by 32%, and reduced hair fall by over 40% — all vs coconut oil placebo. This is RCT-level evidence. Here is what the research actually says about how essential oils work on hair — and why concentration and combination are everything.

Harvard researchers found that cortisol doesn't damage hair follicles directly.
It stops the dermal papilla from producing a molecule called Gas6 — the signal that activates resting follicle stem cells. When Gas6 was added back, stem cells reactivated even under stress conditions. Cortisol is not the enemy.
 The molecule it suppresses is the target. Here is what that changes.

Pelage Pharmaceuticals raised $120 million. Veradermics secured $150 million.
PP405 just presented at AAD 2026 and moves toward Phase 3. Hair loss is biopharma's next frontier. The pipeline is real, the science is serious, and the results are years away. Here is what $270 million is buying — and what you can do right now that the pipeline cannot yet offer.

  Clascoterone just produced 539% relative improvement in hair count vs placebo
across 1,465 men — by blocking DHT at the follicle receptor, not systemically. No sexual side effects. No systemic hormone disruption. Just local DHT  inhibition at the site where it causes harm. This is the mechanism Laritelle's topical botanical formulation has always used. The pharmaceutical field just validated it at scale.